Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period

AIM: To investigate seven CA125 criteria to monitor progressive ovarian cancer among patients with stage IC–IV disease. MATERIALS & METHODS: Four criteria were used to asses CA125 increments starting from concentrations ≥35 U/ml and three criteria to asses increments starting from concentrations...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu Hassan, Suher O, Nielsen, Dorte L, Tuxen, Malgorzata K, Petersen, Per H, Sölétormos, György
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583662/
https://www.ncbi.nlm.nih.gov/pubmed/28884012
http://dx.doi.org/10.4155/fsoa-2017-0023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583662/
https://www.ncbi.nlm.nih.gov/pubmed/28884012
http://dx.doi.org/10.4155/fsoa-2017-0023

Ejemplares similares